Meyer E.
- Country
- France
- Department
- 2012: Cardiology
Research Overview
- Effect of Olpasiran on Major Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease and Elevated Lipoprotein(a): A Randomized, Placebo-Controlled Study
- Effect of Muvalaplin on Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: A Phase 3 Randomized Trial
- Phase 3 Randomized Study Comparing Asundexian and Apixaban for Stroke Prevention in Atrial Fibrillation Patients at Risk
Data & Insights
Has run more than one trial at 653 of 1410 partner sites.
Specializations
Cardiac Arrhythmia Management
Investigates therapeutic approaches for atrial arrhythmias and atrial fibrillation, with particular focus on prevention strategies following cardiac procedures. Explores innovative treatments including left atrial appendage closure and antithrombotic therapies.
- Patent Foramen Ovale Management
- Stroke Prevention
- Antithrombotic Strategies
Cardiovascular Disease Treatment
Focuses on advanced therapies for acute myocardial infarction and atherosclerotic cardiovascular disease. Studies novel approaches in lipid management and plaque reduction strategies for patients with coronary conditions.
- Coronary Artery Disease
- LDL-C Management
- Atherosclerotic Plaque Progression
Metabolic and Cardiovascular Prevention
Specializes in preventive cardiology for patients with type 2 diabetes and cardiovascular risk factors. Investigates combination therapies for improving cardiovascular outcomes in high-risk populations without established cardiovascular disease.
- Diabetic Cardiovascular Care
- Primary Prevention Strategies
- Cardiovascular Risk Reduction
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.